Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation
Open Access
- 1 June 2019
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 4 (6) , 526-548
Abstract
Congestive heart failure (CHF) is commonly associated with atrial fibrillation (AF), and their combined presentation confers a worse prognosis than either condition alone.1 Treatment of both conditions implies use of specific drugs for CHF plus antithrombotic agents for stroke prevention. In addition, management strategies and outcomes may be affected by the etiology of CHF, namely ischemic cardiomyopathy (ICM) or nonischemic cardiomyopathy (NICM) because the prescription of antithrombotic therapies might be different and could affect prognosis in terms of death, stroke/systemic embolism (SE), and bleeding.2,3 The aim of our study was to assess the treatment strategies in terms of antithrombotic and CHF therapies and 1-year clinical outcomes in patients with newly diagnosed AF and concomitant CHF stratified by etiology (ICM vs NICM) enrolled in the Global Anticoagulant Registry in the Field–Atrial Fibrillation (GARFIELD-AF) registry.Keywords
This publication has 37 references indexed in Scilit:
- Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD RegistryPLOS ONE, 2013
- Survival in Patients With Severe Ischemic Cardiomyopathy Undergoing Revascularization Versus Medical TherapyCirculation, 2012
- Incremental Reduction in Risk of Death Associated With Use of Guideline‐Recommended Therapies in Patients With Heart Failure: A Nested Case‐Control Analysis of IMPROVE HFJournal of the American Heart Association, 2012
- International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)American Heart Journal, 2012
- Atrial Fibrillation in Heart Failure is Associated with an Increased Risk of Death Only in Patients with Ischaemic Heart DiseaseEuropean Journal of Heart Failure, 2010
- Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosisAmerican Heart Journal, 2008
- Differences in management and outcome of ischemic and non-ischemic cardiomyopathyInternational Journal of Cardiology, 2008
- Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failureEuropean Heart Journal, 2006
- Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on MortalityCirculation, 2003
- Underlying Causes and Long-Term Survival in Patients with Initially Unexplained CardiomyopathyNew England Journal of Medicine, 2000